Related Experiment Video
Updated: Aug 19, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?]
T Fink1, K H Kuck1, A Metzner2
1Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.
Insights
The updated European Society of Cardiology (ESC) guidelines offer new recommendations for managing ventricular arrhythmias and preventing sudden cardiac death. These guidelines focus on diagnostics, therapies, and device treatments, including implantable cardioverter defibrillators (ICDs).
Area of Science:
- Cardiology
- Electrophysiology
Context:
- The European Society of Cardiology (ESC) has released updated guidelines for ventricular arrhythmia management and sudden cardiac death prevention.
- These guidelines were presented at the annual ESC meeting in London.
Purpose:
- To provide an extensive update on the diagnostics, drug therapy, interventional, and device therapy for ventricular arrhythmia.
- To refine recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prevention of sudden cardiac death.
- To expand recommendations for catheter ablation of ventricular arrhythmias based on recent clinical trials.
Summary:
- The guidelines extensively update recommendations for diagnosing and treating ventricular arrhythmias.
- New guidance is provided for implantable cardioverter defibrillator (ICD) therapy in sudden cardiac death prophylaxis.
- Recommendations for catheter ablation have been expanded, incorporating recent clinical trial data.
- The guidelines align with the 2013 consensus report on hereditary arrhythmia syndromes from AHA, EHRA, and APHRS.
Impact:
- These updated guidelines will inform clinical practice for managing patients with ventricular arrhythmias.
- The recommendations aim to improve the prevention of sudden cardiac death through optimized therapeutic strategies.
- The integration of new evidence, particularly from clinical trials on catheter ablation, will enhance treatment efficacy.
Abstract:
The new European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmia and the prevention of sudden cardiac death, recently published at the annual ESC meeting in London, contain an extensive update of the recommendations for the diagnostics, drug therapy, interventional and device therapy of ventricular arrhythmia. The new recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prophylaxis of sudden cardiac death can be seen as a focused update of the previously published guidelines. Pre-existing recommendations for catheter ablation of ventricular arrhythmias have been partly extensively expanded with respect to the results of recent clinical trials. The guideline committee also adapted their recommendations regarding the hereditary arrhythmia syndromes to the 2013 consensus report of the American Heart Association (AHA), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society (APHRS).
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
05:15Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
Published on: June 21, 2024
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Dysrhythmias VI: Management of Dysrhythmias
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias